372 related articles for article (PubMed ID: 10514384)
1. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.
Brabletz T; Jung A; Dag S; Hlubek F; Kirchner T
Am J Pathol; 1999 Oct; 155(4):1033-8. PubMed ID: 10514384
[TBL] [Abstract][Full Text] [Related]
2. [beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma].
Brabletz T; Jung A; Dag S; Reu S; Kirchner T
Verh Dtsch Ges Pathol; 2000; 84():175-81. PubMed ID: 11217438
[TBL] [Abstract][Full Text] [Related]
3. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
Tetsu O; McCormick F
Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
[TBL] [Abstract][Full Text] [Related]
4. Identification of c-MYC as a target of the APC pathway.
He TC; Sparks AB; Rago C; Hermeking H; Zawel L; da Costa LT; Morin PJ; Vogelstein B; Kinzler KW
Science; 1998 Sep; 281(5382):1509-12. PubMed ID: 9727977
[TBL] [Abstract][Full Text] [Related]
5. Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma2 chain and MT1-MMP in colorectal carcinomas.
Hlubek F; Spaderna S; Jung A; Kirchner T; Brabletz T
Int J Cancer; 2004 Jan; 108(2):321-6. PubMed ID: 14639622
[TBL] [Abstract][Full Text] [Related]
6. Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells.
Li Q; Dashwood RH
J Biol Chem; 2004 Oct; 279(44):45669-75. PubMed ID: 15331612
[TBL] [Abstract][Full Text] [Related]
7. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
8. Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas.
Brabletz T; Herrmann K; Jung A; Faller G; Kirchner T
Am J Pathol; 2000 Mar; 156(3):865-70. PubMed ID: 10702403
[TBL] [Abstract][Full Text] [Related]
9. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.
Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S
Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283
[TBL] [Abstract][Full Text] [Related]
10. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
Morin PJ; Sparks AB; Korinek V; Barker N; Clevers H; Vogelstein B; Kinzler KW
Science; 1997 Mar; 275(5307):1787-90. PubMed ID: 9065402
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
[TBL] [Abstract][Full Text] [Related]
12. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis.
Koh TJ; Bulitta CJ; Fleming JV; Dockray GJ; Varro A; Wang TC
J Clin Invest; 2000 Aug; 106(4):533-9. PubMed ID: 10953028
[TBL] [Abstract][Full Text] [Related]
13. Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin.
Hlubek F; Jung A; Kotzor N; Kirchner T; Brabletz T
Cancer Res; 2001 Nov; 61(22):8089-93. PubMed ID: 11719433
[TBL] [Abstract][Full Text] [Related]
14. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.
Takahashi M; Tsunoda T; Seiki M; Nakamura Y; Furukawa Y
Oncogene; 2002 Aug; 21(38):5861-7. PubMed ID: 12185585
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells.
Hawcroft G; D'Amico M; Albanese C; Markham AF; Pestell RG; Hull MA
Carcinogenesis; 2002 Jan; 23(1):107-14. PubMed ID: 11756231
[TBL] [Abstract][Full Text] [Related]
16. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
17. Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas.
Zhai Y; Wu R; Schwartz DR; Darrah D; Reed H; Kolligs FT; Nieman MT; Fearon ER; Cho KR
Am J Pathol; 2002 Apr; 160(4):1229-38. PubMed ID: 11943708
[TBL] [Abstract][Full Text] [Related]
18. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
[TBL] [Abstract][Full Text] [Related]
19. Gut-enriched Krüppel-like factor regulates colonic cell growth through APC/beta-catenin pathway.
Stone CD; Chen ZY; Tseng CC
FEBS Lett; 2002 Oct; 530(1-3):147-52. PubMed ID: 12387883
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
